Cargando…

Transcriptome dynamics of the microRNA inhibition response

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Wen, Jiayu, Leucci, Eleonora, Vendramin, Roberto, Kauppinen, Sakari, Lund, Anders H., Krogh, Anders, Parker, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872088/ https://www.ncbi.nlm.nih.gov/pubmed/26861627 http://dx.doi.org/10.1093/nar/gkw091

Ejemplares similares

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2015)

microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus
por: Leucci, Eleonora, et al.
Publicado: (2013)

miRMaid: a unified programming interface for microRNA data resources
por: Jacobsen, Anders, et al.
Publicado: (2010)

MicroRNA-143 down-regulates Hexokinase 2 in colon cancer cells
por: Frankel, Lisa B, et al.
Publicado: (2012)

MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells
por: Gregersen, Lea H., et al.
Publicado: (2010)

Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3
por: De Troyer, Linde, et al.
Publicado: (2020)

Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis
por: Suzuki, Hiroshi I., et al.
Publicado: (2013)

Inhibition of microRNA function by antimiR oligonucleotides
por: Stenvang, Jan, et al.
Publicado: (2012)

Discovering the first microRNA-targeted drug
por: Lindow, Morten, et al.
Publicado: (2012)

Accurate transcriptome-wide prediction of microRNA targets and small interfering RNA off-targets with MIRZA-G
por: Gumienny, Rafal, et al.
Publicado: (2015)

MicroRNA-218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2
por: Mu, Lijun, et al.
Publicado: (2022)

Development of microRNA therapeutics is coming of age
por: van Rooij, Eva, et al.
Publicado: (2014)

Analysis of primary microRNA loci from nascent transcriptomes reveals regulatory domains governed by chromatin architecture
por: Bouvy-Liivrand, Maria, et al.
Publicado: (2017)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
por: Tian, Faqing, et al.
Publicado: (2019)

MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1
por: Jiang, Qian, et al.
Publicado: (2022)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020)

MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma
por: Shan, Ying, et al.
Publicado: (2022)

MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1
por: Wang, Ting, et al.
Publicado: (2023)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway
por: Wang, Kai, et al.
Publicado: (2021)

microRNA-34a overexpression inhibits cell migration and invasion via regulating SIRT1 in hepatocellular carcinoma
por: Zhou, Jianhui, et al.
Publicado: (2019)

MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1
por: Wu, Deyao, et al.
Publicado: (2022)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

MiR-492 impairs the angiogenic potential of endothelial cells
por: Patella, Francesca, et al.
Publicado: (2013)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

MirGeneDB 2.0: the metazoan microRNA complement
por: Fromm, Bastian, et al.
Publicado: (2020)

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
por: Iorio, Marilena V, et al.
Publicado: (2017)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension
por: Bertero, Thomas, et al.
Publicado: (2022)

Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015)

MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1
por: E, Lusha, et al.
Publicado: (2020)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemia
por: Jin, Fengyan, et al.
Publicado: (2021)

Circulating extracellular vesicle-encapsulated microRNA as screening biomarkers for intraductal papillary mucinous neoplasm
por: Sato, Yuki, et al.
Publicado: (2021)

microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer
por: Crone, Stephanie Geisler, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h20o0267gm0edbijjorplsjgc1